精液中存活的顶体完整人类精子作为精液质量和生育状态的标志物
研究利用图像细胞术定量精液中存活顶体完整精子,并在156例生育治疗患者、54例已证实生育男性和10例志愿者中评估其与精液质量、生育状态及妊娠率的关系。结果显示该指标与精液质量差、男性因素不育及需ICSI治疗相关,且对是否需ICSI的分类优于传统精液参数。
要点
- 图像细胞术可简便、无偏地定量精液中存活顶体完整精子,重复测量变异系数为3.7%。
- 精液质量差者存活顶体完整精子比例低于精液质量正常者(中位数32.6% vs 49.3%,P=0.0012)。
- 男性因素不育者存活顶体完整精子总数低于已证实生育男性(中位数35 vs 97百万,P=1×10-7)。
核心结论
- 图像细胞术可标准化测量精液中顶体competent精子数量,可能作为男性生育力的新生物标志物。
- 精液中顶体competent精子数量较少,在评估男性生殖功能时可能是有价值的指标。
研究设计与样本
- 研究使用志愿者洗涤精液样本和获能swim-up组分开发检测方法。
- 随后评估156例生育治疗患者、54例已证实生育男性和10例志愿者的洗涤精液,比较顶体状态与其他精液参数、生育状态、生育治疗及妊娠率。
主要发现
- 精液质量差者存活顶体完整精子比例低于精液质量正常者(中位数32.6% vs 49.3%,P=0.0012)。
- 不育夫妇中精液参数正常男性有44%其存活顶体完整精子比例低于观察到的中位比例46%。
- 男性因素不育者存活顶体完整精子总数低于已证实生育男性(中位数35 vs 97百万,P=1×10-7)。
- 接受一个或多个ICSI周期的夫妇中男性存活顶体完整精子比例低于仅接受IUI的夫妇中男性(44.4% vs 62.0%,P=0.002)。
- 存活顶体完整精子比例在分类夫妇是否需要ICSI方面似乎优于传统精液参数。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要更大规模的不育夫妇队列来证实该检测在估计个体生育潜力方面的临床应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is it possible, in an unbiased and clinical relevant way, to determine the number of viable acrosome-intact human spermatozoa in ejaculates and to use this as a measure of fertility chances? SUMMARY ANSWER: Image cytometry enables easy and unbiased quantification of viable acrosome-intact spermatozoa and it correlates with semen quality and fertility status. WHAT IS KNOWN ALREADY: The presence of the acrosome and its ability to respond to physiological inducers (e.g. progesterone) in the female reproductive tract at the appropriate time and place is required for fertilization. However, the available assays are labor intensive and therefore not used clinically. STUDY DESIGN, SIZE, DURATION: Washed semen samples and capacitated swim-up fractions from volunteers were used to develop the assay. Subsequently washed ejaculates from patients in fertility treatment (n = 156), proven fertile men (n = 54) and volunteers (n = 10) were assessed to evaluate the number of acrosome-intact spermatozoa in the ejaculate (acrosomal status) and compared to other semen parameters, fertility status, fertility treatments and pregnancy rates. PARTICIPANTS/MATERIALS, SETTING, METHODS: Image cytometry was used to assess the fluorescence intensity of Pisum sativum agglutinin and Propidium iodide. MAIN RESULTS AND THE ROLE OF CHANCE: The assay was validated by inducing the acrosome reaction in swim-up-purified and capacitated spermatozoa with progesterone and ionomycin, and in repeated acrosomal status measurements of washed ejaculates a small coefficient of variation (3.7%) was observed. Men with poor semen quality had fewer viable acrosome-intact spermatozoa in the ejaculate (P = 0.0012; median 32.6% vs. 49.3%). A large proportion (44%) of normozoospermic men from infertile couples had less than the observed median fraction (46%) of viable acrosome-intact spermatozoa in the ejaculate. Furthermore, the total number of viable acrosome-intact spermatozoa was significantly lower among men with male factor infertility compared to fertile men (median 35 vs. 97 mill, P = 1 × 10-7). Men from couples going through one or more ICSI cycles had significant fewer viable acrosome-intact spermatozoa than men from couples who only underwent IUI (P = 0.002; 44.4% vs. 62.0%) and the fraction of viable acrosome-intact spermatozoa appeared better than classical semen parameters in classifying whether or not couples needed ICSI. A positive, although non-significant, tendency toward ongoing pregnancy with an increasing number of viable acrosome-intact spermatozoa was observed (P = 0.2). LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: Even larger cohorts of infertile couples are needed to substantiate the clinical application of the assay in regard to estimation of fertility potential of an individual. WIDER IMPLICATIONS OF THE FINDINGS: The presented assay makes it possible to measure the number of acrosome competent spermatozoa in an ejaculate in a standardized manner and hence may serve as a new biomarker for male fertility. Few spermatozoa in an ejaculate are acrosome competent and it might be a valuable measure when evaluating male reproductive function. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by grants from the Innovation Fund Denmark. M.G. and S.K. work at ChemoMetec, which produces the image cytometer used in the study, M.G. hold shares in the company. The other authors have no conflict of interest.
引用
- Egeberg Palme DL, Rehfeld A, Bang AK, et al. Viable acrosome-intact human spermatozoa in the ejaculate as a marker of semen quality and fertility status. Hum Reprod. 2018. PMID: 29304248. doi:10.1093/humrep/dex380
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。